Divis Laboratories reports 12% rise in Q3 consolidated net profit

06 Feb 2016 Evaluate

Divis Laboratories has reported results for third quarter ended December 31, 2015.  

The company has reported 11.78% rise in its net profit at Rs 246.56 crore for the quarter ended December 31, 2015 as compared to Rs 220.58 crore for the same quarter in the previous year. The company’s total income has increased by 7.03% to Rs 868.07 crore for the quarter under review from Rs 811.06 crore for the corresponding quarter of the previous year.  

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×